Filings

2 documents · 2 matches

1. ADAPY Adaptimmune Therapeutics PLC 10-Q 2025-08-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, changes to fiscal and monetary policy, tighter credit, and higher interest rates, could materially adversely affect the Company by, for example
   1 match in this document Show context Copy citation

2. ADAPY Adaptimmune Therapeutics PLC 10-Q 2025-05-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, changes to fiscal and monetary policy, tighter credit, and higher interest rates, could materially adversely affect the Company by, for example
   1 match in this document Show context Copy citation